Pashu Sandesh, 23rd October 2018
Credence Research has presented a report on the Global Poultry Market scenario.Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. They offer customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Important findings of the report are summarised below:
The global poultry health market is expected to reach US$ 11,506.3 Mn by 2026, and exhibit steady compound annual growth rate of 7.1% during the forecast period from 2018 to 2026. Good poultry health management is essential for poultry production since culturing a flock with best genetic potential will not grow efficiently if they are diseased or infected. Infectious disease causing agents spread very quickly through the flock due to high stocking densities in poultry farms. Therefore, for effective poultry health management, the basic aim is prevention of infection or parasite onset, or discovery at an early stage; and early treatment. As the global population is consistently increasing, the demand for livestock and animal products is also correspondingly growing. Changing lifestyle, high demand for protein and lean foods has led to growing uptake of poultry food items. The poultry health market mainly comprises drugs and diagnostic tools used for ensuring poultry flock bred for consumption such as chicken, geese, ducks, turkey and so on.
Impetus on Disease Prevention to render Dominant Status to Vaccines
Meat consumers are becoming increasingly concerned about food safety. Several local and international standards have been put in place for avoiding undesirable substances in food derived from different animals. Evidence is also available suggesting that chicken is the most prominent carrier of microorganisms causing food poisoning in humans. Risk of infection from salmonella and campylobacter has been posing as a concern for both consumers and producers. Regulations have been formulated for preventing diseases in poultry birds and vaccines are opined to be crucial in providing immunity from infections. The demand for poultry vaccines is also driven by growing poultry production, greater government initiatives towards livestock immunisation and human wellbeing and heightening demand for white meat. Technological evolution in vaccine manufacturing and growth in poultry healthcare spending are other prominent factors fuelling the poultry vaccines market.
Introduction of DNA Vaccines to Shape the Future Roadmap of the Global Market
With the outbreak of critical diseases such as Newcastle disease, respiratory infections and avian influenza, poultry farmers are increasingly opting for preventive diagnosis of the flock. This not just ensures healthy production but also avoid catastrophic losses to farmers. Technological advancement has also led to introduction of novel vaccines in the market that were previously unavailable. For instance, Merck Animal Health has an active project involving the use of electron beam to inactivate Clostridium perfringens, which will create the novel vaccine to control necrotic enteritis in flock. In November 2017, the US FDA granted approval to first DNA vaccine by AgriLabs for controlling avian influenza. Introduction of DNA vaccines has been opined to be a major milestone in realising the importance of vaccines in poultry health. DNA vaccines have rapid response and can be manufactured faster than conventional counterparts, therefore to play a promising role during the forecast period.
Laboratory Tests such as ELISA to Spearhead the Diagnostics Space
Disease outbreaks, supportive government policies and technological advancements are the key factors that substantiate the pace of poultry diagnostics market. As the incidence of critical infection outbreaks such as of Newcastle disease, respiratory infections, salmonella infections and influenza is on the rise, poultry farmers worldwide are increasingly adopting preventive measures for maintaining poultry health. Outbreaks of such diseases compromise food safety and affect trade of birds and meat products, resulting in significant losses. As a result, continuous efforts are being undertaken to augment awareness in the poultry farmers about the available preventive measures. Laboratory tests currently hold the dominant position in the poultry diagnostics segment while capturing over 50% market share. High specificity, and accuracy, and their proven ability in controlling epidemic outbreaks are attributed to the dominance of this segment. Some of the prominent players in the poultry diagnostics segment are BioinGentech Biotechnology, Thermo Fisher Scientific, Biocheck Smart Veterinary Diagnostics, MEGACOR Diagnostik, IDEXX Laboratories, and others. New product development, rapid innovation in imaging technologies, mergers and acquisitions are the key growth measures observed in the poultry diagnostics market.
Set to Remain the Leading Consumer of Meat Products, North America will Dominate the Market
North America is the largest regional market for poultry health followed by Asia Pacific and Europe. The prominence of North America is mainly contributed by increasing domestic population, greater consumption of meat products, increasing preference to white and lean meat as against red meat. On the other hand, Asia Pacific will witness swift growth during the forecast period, with significant impact coming from key markets of China, Japan and India. The poultry industry in Asia Pacific has been witnessing growth like never before, as the market for protein-rich food is growing, there has been a consistently increasing demand for poultry meat and eggs. The exports of meat products from these regions are also high. Latin America will also undergo rapid market growth during the forecast period on grounds of improving awareness and growing demand for food from ever-growing population.